About sysmex - SSMXF
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
SSMXF At a Glance
Sysmex Corp.
1-5-1 Wakinohama-Kaigandori
Kobe, Hyogo 651-0073
| Phone | 81-78-265-0500 | Revenue | 3.34B | |
| Industry | Medical Specialties | Net Income | 352.04M | |
| Sector | Health Technology | 2025 Sales Growth | 4.403% | |
| Fiscal Year-end | 03 / 2026 | Employees | 10,533 | |
| View SEC Filings |
SSMXF Valuation
| P/E Current | 19.238 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 33.602 |
| Price to Sales Ratio | 3.547 |
| Price to Book Ratio | 3.815 |
| Price to Cash Flow Ratio | 20.44 |
| Enterprise Value to EBITDA | 13.821 |
| Enterprise Value to Sales | 3.497 |
| Total Debt to Enterprise Value | 0.037 |
SSMXF Efficiency
| Revenue/Employee | 316,761.59 |
| Income Per Employee | 33,422.809 |
| Receivables Turnover | 2.74 |
| Total Asset Turnover | 0.782 |
SSMXF Liquidity
| Current Ratio | 2.97 |
| Quick Ratio | 2.304 |
| Cash Ratio | 0.734 |
SSMXF Profitability
| Gross Margin | 53.471 |
| Operating Margin | 17.63 |
| Pretax Margin | 15.982 |
| Net Margin | 10.551 |
| Return on Assets | 8.246 |
| Return on Equity | 11.821 |
| Return on Total Capital | 9.961 |
| Return on Invested Capital | 10.611 |
SSMXF Capital Structure
| Total Debt to Total Equity | 13.958 |
| Total Debt to Total Capital | 12.249 |
| Total Debt to Total Assets | 9.731 |
| Long-Term Debt to Equity | 11.964 |
| Long-Term Debt to Total Capital | 10.498 |